
  • CRO SERVICES
    • cellPrism® Drug Development Platform
      • Immuno-Phenotyping
      • Antibody Testing
      • Immuno-Oncology
      • Target Validation
      • Lymphopenia
      • Neutropenia
      • Severe Anemia
      • Thrombocytopenia
      • Cytokine Release Assay | Cytokine Storm Risk Analysis
    • Additional Services
      • Custom Cell Biology Research Services
      • Molecular Biology Services
      • Co-Culture Systems
      • Cytokine Storm Risk Analysis
      • Pre-Clinical & Clinical Samples
      • Compound Classes
      • Immune Profiling & Flow Cytometry
      • Primary Cell Bank Generation
      • Custom Cell Products
    • Additional Assays
      • ADCC Assays
      • CFC (Colony-Forming Cell) Assays
      • Cancer Stem Cell and Leukemic CFC Assays
      • Myelosuppression & Hematotoxicity Assays
      • Sickle Cell Disease | HbF Protein Induction Assay
      • Antibody Drug Conjugates Toxicity Assay
    • In Vivo Services
      • NOD-SCID Repopulation Assays
      • Stem Cell Mobilization Assays
      • 5-FU Assays
  • SHOP PRODUCTS
    • ReachBio Products
      • Human Peripheral Blood
      • Human Cord Blood
      • Human Bone Marrow Cells
      • Mesenchymal Cells & Media
      • ColonyGEL™ Media for CFC Assays
      • Custom Primary Cells
    • Product Information
      • Frequently Asked Questions: Products
      • References (Products)
      • Product Flyers
      • Product Description Sheets
      • Order Information
      • Protocols
      • Technical Support Documents
  • PUBLICATIONS
    • Poster Abstracts
      • Bystander Effects of ADCs...
      • An Ex Vivo Flow Cytometry Platform...
      • MORE...
    • White Papers
      • Off-Target Toxicity and Linker Stability
      • A Platform for Screening Drugs to Treat Sickle Cell Disease and Other Hemoglobinopathies
      • PBMC Tips + Tricks
    • Publications
      • Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2
      • CoREST Complex-Service Histone Deacetylase Inhibitors...
      • Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity...
      • MORE...
  • ABOUT
    • About ReachBio
      • News
      • Testimonials
      • Our Expertise
      • Associations | Affiliations
      • Career Opportunities
      • CRO Capabilities
      • Management
      • Blog
  • CONTACT
    Features & Benefits of Our MSCs

    Pre-Qualified Mesenchymal Cells

    Each batch of ReachBio Research Lab’s Pre-Qualified Mesenchymal (Stromal) Cells are derived from normal human bone marrow and have the following characteristics

    • Multiple replicate vials derived from single donors
    • Minimally culture expanded
    • Phenotypically characterized by flow cytometry
    • Known plating efficiencies
    • Batch-specific protocols provided
    Background

    Mesenchymal cells (also known as stromal cells or non-hematopoietic cells) are a component of the bone marrow microenvironment. Although they function to support and regulate hematopoietic cell development, it is their capacity to differentiate into multiple lineages including bone, cartilage, muscle, tendon and fat, that has caused renewed interest in these cells by stem cell biologists and researchers within the regenerative medicine and tissue engineering fields. 

    Research & Development Applications
    ReachBio now offers superior pre-qualified human mesenchymal cells for research & development applications*
    • Drug Screening
    • Regenerative Medicine Research
    • Tissue Engineering Research
    • Cell and Gene Therapy Research
    • Stem Cell and Developmental Biology Research
    • Immunomodulation Studies
    • Adipogenic Studies
    Each batch of ReachBio's Pre-Qualified Mesenchymal Cells are fully characterized as follows:
    • Cell surface phenotype - determined by flow cytometry
    • Plating efficiency - tested and quantified
    • Functional differentiation potential - tested and verified
    Additional characteristics:
    • Derived from normal human marrow
    • Minimally culture expanded in optimized media formulation
    • Multiple replicate vials from single donors
    • Batch-specific protocols provided
    • Optimized culture and differentiation media available
    *For in vitro research use only. Not for therapeutic use or injection into humans for any purpose.
    Intended Use
    The intended use of these products is for in vitro research purposes only.
     
    These products are not intended for human or veterinary use in vivo. 
     
    These products are not to be used for any diagnostic, therapeutic or clinical applications whatsoever.
    Mountain View



    • © 2019 ReachBio LLC

                 PRIVACY POLICY